Leapfrog Bio
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
10 Stuart St, Kingston, Ontario, K7L 2V5...Website
leapfrog.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Leapfrog Bio
Leapfrog Bio is focused on developing targeted therapies for cancers driven by genetic mutations that are resistant to conventional treatments. Utilizing their proprietary OncoSLX platform, they identify and target the hidden genetic vulnerabilities associated with loss-of-function mutations in tumors. Their lead product candidate, LFB190, is a promising BET inhibitor aimed at treating cancers with EP300 mutations, addressing significant unmet clinical needs. The company aims to improve patient outcomes by accelerating drug development and reducing translational risks through innovative pharmacogenetic approaches.Explore more
Leapfrog Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Leapfrog Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Leapfrog Bio launches new products
Check out if Leapfrog Bio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Leapfrog Bio has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Leapfrog Bio has new funding data
Earning: See what the market has to say on Leapfrog Bio recently announced quarterly report
Click to see if Leapfrog Bio had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Leapfrog Bio
Leapfrog Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Leapfrog Bio
Compare insights from companies similar to Leapfrog Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Leapfrog Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Leapfrog Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Leapfrog Bio.
Leapfrog Bio Tech Stack
A closer look at the technologies used by Leapfrog Bio
See more technologies
Leapfrog Bio News & Media
New Data Underscoring Ability of Leapfrog Bio’s OncoSLX Platform to Identify Drug Retargeting Opportunities for Treating Cancer Published in Nature Portfolio Journal
-- Study highlights importance of cancer driver biology in translating results from lab to patients -- -- Findings validate proprietary OncoSLX Platform™, a pharmacogenetic approach that captures the full spectrum of drug biology -- -- Continuing to advance lead asset LFB190, a BET inhibitor, targeting EP300 loss‑of‑function cancers; expect to initiate Phase 1b/2a clinical trial in solid tumors in mid-2026 -- SOUTH SAN FRANCISCO, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Leapfrog Bio, a clinicalLeapfrog Bio Presents Novel Genetic Sensitizing Mutation Linked to BET Inhibitors and Clinical Development Plans for Lead Product Candidate at the AACR Special Conference in Cancer Research
Leapfrog Bio announced AACR presentation describing the discovery, characterization, and clinical development plan for lead drug LFB-190.Leapfrog Bio Announces Publication in Nature PJ Precision Oncology Validating its Proprietary Precision PGx Platform™
Leapfrog Bio today announced a publication in Nature PJ Precision Oncology describing and validating its Precision PGx Platform™
Read more news
Top Business Services Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Leapfrog Bio
Sign Up For FreeTo access detailed company insights
Leapfrog Bio is focused on developing targeted therapies for cancers driven by genetic mutations that are resistant to conventional treatments. Utilizing their proprietary OncoSLX platform, they identify and target the hidden genetic vulnerabilities associated with loss-of-function mutations in tumors. Their lead product candidate, LFB190, is a pro... Read More
